01.03.2022

The most innovative longevity research could bag 50k CHF thanks to Maximon, which is launching its first Prize for Translational Research in Longevity.

Switzerland-based Maximon, Europe’s first longevity company builder, is launching the Maximon Longevity Prize for Translational Research, awarding breakthrough research in the field of longevity that has the potential to substantially increase the healthspan or lifespan of humans. Maximon has pledged 50,000 CHF for the winner of the prize and is committed to attracting more donors and sponsors to further support the cause